The mental health telehealth landscape has fundamentally shifted. What was once a booming industry promising easy access to psychiatric care has contracted sharply following federal prosecutions, company shutdowns, and regulatory investigations that exposed serious prescribing abuses. If you're searching for online mental health treatment in 2026, your options are now far more limited than they were just a few years ago, particularly for conditions requiring controlled medications.

What Happened to the Telehealth Mental Health Boom?

The collapse didn't happen overnight. Between 2022 and 2024, several high-profile telehealth providers either shut down entirely or faced severe legal consequences. Done Global, once a leading ADHD-focused telehealth service, faced federal prosecution in 2024 when its top executives were criminally charged for allegedly operating what prosecutors described as "a prescription mill" for ADHD stimulants. The company is now effectively defunct, leaving thousands of patients scrambling to find alternative care.

Ahead, another major player, ceased operations entirely in 2022 due to financial difficulties and operational challenges. Cerebral, once valued at over $4 billion, stopped accepting new patients for ADHD stimulant prescriptions in May 2022 and paid $3.6 million in settlements over prescribing practices. These dramatic developments have fundamentally reshaped how telehealth companies approach controlled substance prescribing, shifting from an "easy access" model to far more conservative, compliance-focused approaches.

Which Telehealth Providers Are Still Operating, and What Can They Actually Prescribe?

The current landscape is fragmented. Some platforms remain active and operational, but they've adopted strict policies about what medications they will and won't prescribe. Understanding these limitations is crucial before signing up for care.

Talkiatry stands out as one of the most comprehensive options for serious mental health concerns. Unlike direct-to-consumer apps, Talkiatry employs fully licensed psychiatrists who can diagnose and treat a broad spectrum of mental health conditions, including prescribing controlled substances when medically appropriate. The platform covers 43 states, accepts most major insurance plans, and typically costs between $25 and $400 per visit depending on insurance, with initial evaluations running $250 to $300 without insurance. However, some patients report longer wait times for initial appointments, ranging from one to three weeks.

Brightside focuses exclusively on depression, anxiety, PTSD, OCD, and insomnia, but explicitly does not treat ADHD. The platform takes a conservative medication approach, refusing to prescribe any controlled substances. It covers all 50 states, accepts many major insurance plans, and costs $95 per month for medication management or $349 per month for therapy plus medication. Brightside works well for patients seeking straightforward depression or anxiety treatment with SSRIs or similar non-controlled medications, but it's not suitable for those needing ADHD care or controlled anxiety medications.

Cerebral has dramatically scaled back operations after its 2022 regulatory challenges. While still operational, the platform now takes an extremely conservative approach to prescribing. It no longer accepts new stimulant prescriptions for ADHD patients, offers no benzodiazepines, and refuses controlled sleep medications. Existing ADHD patients on stimulants were gradually transitioned to alternative providers or medications. The platform's rocky history and subscription model, which some users find difficult to cancel, make it a less attractive option compared to newer alternatives.

Teladoc, MDLive, and Amwell serve millions of patients for urgent care, primary care, and basic mental health needs. However, all three have strict policies against prescribing controlled substances via telehealth. They do not prescribe ADHD stimulants, benzodiazepines, or controlled sleep medications. These platforms excel at treating mild to moderate depression and anxiety with standard antidepressants, providing therapy referrals, and handling non-controlled medication refills. They're often covered fully by employer health plans, making them cost-effective for basic needs.

What Medications Can Telehealth Platforms Still Prescribe?

While controlled substances have become nearly impossible to obtain through telehealth, all active platforms can prescribe non-controlled psychiatric medications. This represents the core of what modern telehealth mental health care actually offers.

• Antidepressants (SSRIs and SNRIs): All active telehealth platforms can prescribe selective serotonin reuptake inhibitors like Zoloft and Prozac, as well as serotonin-norepinephrine reuptake inhibitors, making these the most accessible medications for depression and anxiety treatment online.
• Non-controlled anxiety medications: Platforms can prescribe medications like Buspar and Vistaril, which are not classified as controlled substances and therefore face fewer regulatory restrictions than benzodiazepines.
• ADHD alternatives: For ADHD patients, telehealth providers offer non-stimulant options like Strattera and Wellbutrin, though these are generally considered less effective than traditional stimulants for many patients.
• Mood stabilizers: Medications for bipolar disorder and other mood conditions are available through most platforms, provided they are non-controlled substances.
• Non-controlled sleep aids: Patients with insomnia are typically offered alternatives like trazodone or hydroxyzine, along with cognitive behavioral therapy for insomnia (CBT-I), rather than prescription sleep medications like Ambien.

How to Navigate the Current Telehealth Mental Health Landscape

Finding the right telehealth provider requires understanding your specific needs and the limitations of each platform. Here are practical steps to guide your decision.

• Assess your condition: If you have ADHD requiring stimulant medication, depression or anxiety manageable with SSRIs, or other non-controlled conditions, telehealth remains viable. If you need benzodiazepines or controlled sleep medications, you'll likely need in-person psychiatric care or a specialized platform like Talkiatry.
• Check insurance coverage: Most major telehealth platforms accept insurance, which can significantly reduce out-of-pocket costs. Verify that your specific insurance plan is accepted before signing up, as coverage varies widely by provider and state.
• Verify state availability: While most established telehealth platforms now operate nationwide, some specialists like Talkiatry have limited state availability due to psychiatric licensing requirements. Confirm that your state is covered before committing to a provider.
• Understand prescribing policies upfront: Before enrolling, explicitly ask what medications each platform will and won't prescribe. This prevents disappointment after you've already completed an intake appointment and paid for an evaluation.
• Consider hybrid care: If your condition requires controlled medications, consider using telehealth for therapy or non-controlled medication management while seeking in-person psychiatric care for controlled substance prescriptions.

What Does This Mean for Patients Seeking Mental Health Care?

The regulatory crackdowns that reshaped telehealth were necessary. Investigations revealed that some platforms were prescribing ADHD stimulants with minimal evaluation, contributing to misuse and fraud. However, the pendulum has swung so far in the opposite direction that patients with legitimate mental health needs now face genuine barriers to care.

For patients with straightforward depression or anxiety, telehealth remains a viable, accessible option. The platforms that remain operational generally provide competent care for these conditions at reasonable costs. But for patients with ADHD, treatment-resistant anxiety, or insomnia requiring prescription sleep aids, the landscape has become significantly more challenging. These patients often have no choice but to seek in-person psychiatric care, which typically involves longer wait times and higher costs.

The broader lesson is that the telehealth mental health industry has matured from a "move fast and break things" startup mentality into a more cautious, regulated space where patient safety and quality care take precedence over convenience alone. For some patients, that's an improvement. For others, it means fewer options and more frustration.